SNY vs. NVO
Compare and contrast key facts about Sanofi (SNY) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNY or NVO.
Key characteristics
| SNY | NVO | |
|---|---|---|
| YTD Return | -0.54% | 20.50% |
| 1Y Return | -5.21% | 49.11% |
| 3Y Return (Ann) | 1.63% | 50.34% |
| 5Y Return (Ann) | 6.53% | 40.98% |
| 10Y Return (Ann) | 2.89% | 20.58% |
| Sharpe Ratio | -0.14 | 1.53 |
| Daily Std Dev | 26.73% | 32.48% |
| Max Drawdown | -46.65% | -71.28% |
| Current Drawdown | -10.40% | -8.29% |
Fundamentals
| SNY | NVO | |
|---|---|---|
| Market Cap | $122.65B | $568.92B |
| EPS | $2.30 | $2.68 |
| PE Ratio | 21.36 | 47.33 |
| PEG Ratio | 0.84 | 2.40 |
| Revenue (TTM) | $46.29B | $232.26B |
| Gross Profit (TTM) | $31.70B | $148.51B |
| EBITDA (TTM) | $12.20B | $109.81B |
Correlation
The correlation between SNY and NVO is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNY vs. NVO - Performance Comparison
In the year-to-date period, SNY achieves a -0.54% return, which is significantly lower than NVO's 20.50% return. Over the past 10 years, SNY has underperformed NVO with an annualized return of 2.89%, while NVO has yielded a comparatively higher 20.58% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNY vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNY vs. NVO - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 3.84%, more than NVO's 0.79% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | 3.84% | 3.82% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.77% | 4.19% | 3.47% |
NVO Novo Nordisk A/S | 0.79% | 0.71% | 0.84% | 0.94% | 1.33% | 1.51% | 1.97% | 1.52% | 2.87% | 0.92% | 1.43% | 1.23% |
Drawdowns
SNY vs. NVO - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum NVO drawdown of -71.28%. Use the drawdown chart below to compare losses from any high point for SNY and NVO. For additional features, visit the drawdowns tool.
Volatility
SNY vs. NVO - Volatility Comparison
Sanofi (SNY) has a higher volatility of 8.00% compared to Novo Nordisk A/S (NVO) at 7.39%. This indicates that SNY's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities